Evidence map›Paper›PMID 27742625›Full record

ArticleBMJ open2016

State of the art of chronic spontaneous urticaria in Italy: a multicentre survey to evaluate physicians' and patients' perspectives.

Marco Rimoldi, Oliviero Rossi, Nadia Rota

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMJ open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Management of chronic spontaneous urticaria: a worldwide perspective.The World Allergy Organization journal · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Marco RimoldiStethos Marketing Research Srl, Milan, Italy.
Oliviero RossiAllergy Unit, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.
Nadia RotaNovartis Farma SpA, Origgio, Varese, Italy.
Azienda Ospedaliero-Universitaria Careggi · ITNovartis (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the clinical status of chronic spontaneous urticaria (CSU) and understand treatment approaches in Italy through specialists who treat CSU (dermatologists and allergy specialists) and CSU patients' experience.

designMulticentre survey.

settingOnline structured questionnaires (one for physicians and one for patients).

participantsPhysicians and patients with CSU in Italy.

interventionsNone. PRIMARY/SECONDARY OUTCOMES: Physician and patient attitudes/experiences.

resultsSurvey results from 160 allergy and 160 dermatology specialists show that specialists see a median of 40 (IQR 20-80) patients with CSU/year. While most specialists (56%) know the CSU guidelines, only 27% use them regularly (36% of allergy specialists vs 18% of dermatologists). This is reflected in treatment choices with differences between physicians who use guidelines regularly and those who do not: 91.6% vs 71.7% choose standard-dose, non-sedating antihistamines as first-line treatment; 85.9% vs 56.0% select up-dosing for second-line treatment and 65.3% vs 37.2% add leukotriene receptor antagonists or H

conclusionsIn Italy, the gap between guideline-based care and QoL-related needs in CSU patients affects treatment satisfaction. This information could be used to improve the management of CSU in Italy.

Indexed as

Health Knowledge, Attitudes, PracticeQuality of LifeAccess to InformationAdultChronic DiseaseDisease ManagementFemaleGuideline AdherenceHealth Services Needs and DemandHumansItalyMaleMiddle AgedPatient SatisfactionPhysiciansSurveys and Questionnaireschronic spontaneous urticariamulticenter studypatient assessmentphysician assessmentsurvey

Identifiers

PMID27742625
PMCPMC5073619
OpenAlexW2531622229

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.